Pillar Biosciences, LC-SCRUM-Asia and LSI Medience Announce Liquid Biopsy Screening Collaboration in Lung Cancer
oncoReveal® Essential+ validated at LSI Medience for cfDNA/cfRNA screening in the LC-SCRUM-Asia project, with testing planned to begin in August 2026 NATICK, Mass. and TOKYO, Japan – August 19, 2026 – Pillar Biosciences, Inc. (“Pillar”), LC-SCRUM-Asia and LSI Medience Corporation (“LSI Medience”) today announced a collaboration to support genomic screening of blood-based samples from patients […]